Komori
Other Disclosures7347Mercuria Holdings Co.,Ltd.Financials (excluding banks)

Notice Regarding an Investment in 株式会社Kiviaq by Mercuria Supply Chain Investment Limited Partnership

Mercuria Investment Co., Ltd. made an investment in Kiviaq through a fund it manages and operates. Following the investment, it will support Kiviaq's growth not only financially but also operationally.

Worth reading
65In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

Kibiyaq Pharmacy dispensing pharmacy service
Applicable field (uses covered by this announcement)

Healthcare, dispensing pharmacies, pharmaceutical SCM and logistics

What the company reported numerically
Quantitative Effects

Delivery within 30 minutes at the earliest

Relationship between the counterparty and the company
Mercuria Holdings Co.,Ltd.7347
Relationship with the Company

The relationship consists of an investment through Mercuria Supply Chain Investment Limited Partnership, managed and operated by Mercuria Investment Co., Ltd. Kiviaq is the investee.

CounterpartyKiviaq Co., Ltd.

Head office: Noah Shibadaimon 101, 1-4-4 Shibadaimon, Minato-ku, Tokyo; Representative: Representative Director and CEO Okada Shun (岡田俊); Business: pharmaceutical SCM and dispensing pharmacy operations

Location (as indicated in this announcement)

Noah Shibadaimon 101, 1-4-4 Shibadaimon, Minato-ku, Tokyo

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredKibiyaq Pharmacy dispensing pharmacy service
CounterpartyKiviaq Co., Ltd.
Counterparty overviewHead office: Noah Shibadaimon 101, 1-4-4 Shibadaimon, Minato-ku, Tokyo; Representative: Representative Director and CEO Okada Shun (岡田俊); Business: pharmaceutical SCM and dispensing pharmacy operations
Relationship with the CompanyThe relationship consists of an investment through Mercuria Supply Chain Investment Limited Partnership, managed and operated by Mercuria Investment Co., Ltd. Kiviaq is the investee.
Applicable areaHealthcare, dispensing pharmacies, pharmaceutical SCM and logistics
LocationNoah Shibadaimon 101, 1-4-4 Shibadaimon, Minato-ku, Tokyo
Quantitative EffectsDelivery within 30 minutes at the earliest
Items this document does not state (11)
Contract ValueOffering priceContract DateLaunch dateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because Kiviaq was determined to be a startup capable of redesigning access to healthcare by applying its expertise in SCM, logistics and online pharmacies to challenges in the hospital and pharmacy sectors, including prescription collection, waiting times and stockouts.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding an Investment in 株式会社Kiviaq by Mercuria Supply Chain Investment Limited Partnership | Mercuria Holdings Co.,Ltd. (7347) timely disclosure | Komori